This inventor holds 1 USPTO granted patent. Top assignee: Mylan Laboratories Limited. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Appi Reddy Talatala: Innovator in Pharmaceutical Chemistry
Introduction
Appi Reddy Talatala is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for the preparation of important medicinal compounds. His work has implications for the treatment of various neurological conditions.
Latest Patents
Appi Reddy Talatala holds a patent for a process related to the preparation of oxcarbazepine. The patent, titled "Process for the preparation of oxcarbazepine," describes an improved method for synthesizing 10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide (Oxcarbazepine). This process involves the reaction of 10-methoxy-5H-dibenz[b,f]azepine (10-methoxyiminostilbene) with alkali metal cyanate in the presence of α-hydroxy acids. Additionally, the invention includes a method for preparing carbamazepine from iminostilbene and introduces a novel crystalline form of 10-methoxy carbamazepine.
Career Highlights
Appi Reddy Talatala is currently associated with Mylan Laboratories Limited, a prominent player in the pharmaceutical industry. His work at Mylan has allowed him to focus on innovative solutions that enhance drug formulations and improve patient outcomes. His dedication to research and development has positioned him as a valuable asset in the field.
Collaborations
Throughout his career, Appi has collaborated with talented professionals, including Nageswara Rao Karusala and Uma Sankara Sastry Tummalapally. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Appi Reddy Talatala's contributions to pharmaceutical chemistry, particularly through his patent on oxcarbazepine, highlight his innovative spirit and commitment to improving healthcare solutions. His work continues to impact the industry positively, paving the way for future advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
